Vitamin D deficiency, mortality, and hospitalization in hemodialysis patients with or without protein-energy wasting

Nephron - Clinical Practice

Volumn 119, Issue 3, 2011, Pages

  Fiedler, Roman ^a   Dorligjav, Otgontogoo ^a   Seibert, Eric ^a   Ulrich, Christof ^a   Markau, Silke ^a   Girndt, Matthias ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

25 OH vitamin D 3; Hemodialysis; Hospitalization; Malnutrition; Mortality; Protein energy wasting

Indexed keywords

ALFACALCIDOL; CALCITRIOL; COLECALCIFEROL;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; INFLAMMATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORTALITY; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CALORIE MALNUTRITION; SCORING SYSTEM; STATISTICAL MODEL; SURVIVAL; VITAMIN D DEFICIENCY;

ADULT; AGED; AGED, 80 AND OVER; CALCIFEDIOL; CALCITRIOL; FEMALE; HOSPITALIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROTEIN-ENERGY MALNUTRITION; RENAL DIALYSIS; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 81155158220     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000328927     Document Type: Article

References (36)

1. Holick MF, Schnoes HK, DeLuca HF, Suda T, Cousins RJ: Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. Biochemistry 1971; 10: 2799-2804.
2. Semmler EJ, Holick MF, Schnoes HK, DeLuca HF: The synthesis of 1,25-dihydroxycholecalciferol-a metabolically active form of vitamin D 3 . Tetrahedron Lett 1972; 40: 4147-4150.
3. DeLuca HF: Overview of general physiological features and functions of vitamin D. Am J Clin Nutr 2004; 80(suppl):1689S-1696S.
4. DeLuca HF, Engstrom GW, Rasmussen H: The action of vitamin D and parathyroid hormone in vitro on calcium uptake and release by kidney mitochondria. Biochemistry 1962; 48: 1604-1609.
5. Holick MF: Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
6. Dusso AS, Brown AJ, Slatopolsky E: Vitamin D. Am J Physiol Renal Physiol 2005; 289: 8-28.
7. Dobnig H, Pilz S, Scharnagl H, et al: Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008; 168: 1340-1349. (Pubitemid 351930842)
8. Melamed ML, Michos ED, Post W, Astor B: 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008; 168: 1629-1637.
9. Kuroda T, Shiraki M, Tanaka S, Ohta H: Contributions of 25-hydroxyvitamin D, comorbidities and bone mass to mortality in Japanese postmenopausal women. Bone 2009; 44: 168-172.
10. Matias PJ, Ferreira C, Jorge C, et al: 25-Hydroxyvitamin D 3 , arterial calcifications and cardiovascular risk markers in haemodialysis patients. Nephrol Dial Transplant 2009; 24: 611-618.
11. Melamed ML, Muntner P, Michos ED, et al: Serum 25-hydroxyvitamin D levels and prevalence of peripheral arterial disease. Arterioscler Thromb Vasc Biol 2008; 28: 1179-1185.
12. Michos ED, Melamed ML: Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care 2008; 11: 7-12. (Pubitemid 350295219)
13. Ravani P, Malberti F, Tripepi G, et al: Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 2009; 75: 88-95.
14. Wolf M, Shah A, Gutierrez O, et al: Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007; 72: 1004-1013. (Pubitemid 47530570)
15. Fiedler R, Jehle PM, Dorligschaw O, Osten B, Girndt M: Clinical nutrition scores are superior for the prognosis of haemodialysis patients compared to lab markers and bioelectrical impedance. Nephrol Dial Transplant 2009; 24: 3812-3817.
16. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH: A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 2001; 38: 1251-1263. (Pubitemid 34193111)
17. Pupim LB, Caglar K, Hakim RM, Shyr Y, Ikizler TA: Uremic malnutrition is a predictor of death independent of inflammatory status. Kidney Int 2004; 66: 2054-2060.
18. Stenvinkel P, Heimbürger O, Paultre F, et al: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-1911. (Pubitemid 29197978)
19. Kaysen GA: The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001; 12: 1549-1557. (Pubitemid 32666340)
20. Riella MC: Malnutrition in dialysis: malnourishment or uremic inflammatory response. Kidney Int 2000; 57: 1211-1232. (Pubitemid 30434815)
21. Bhan I, Burnett-Bowie SA, Ye J, Tonelli M, Thadhani R: Clinical measures identify vitamin D deficiency in dialysis. Clin J Am Soc Nephrol 2010; 5: 460-467.
22. Maetani M, Maskarinec, Franke AA, Cooney RV: Association of leptin, 25-hydroxyvitamin D, and parathyroid hormone in women. Nutr Cancer 2009; 61: 225-231.
23. Young KA, Engelman CD, Langefeld CD, et al: Association of plasma vitamin D levels with adiposity in Hispanic and African-Americans. J Clin Endocrinol Metab 2009; 94: 3306-3313.
24. Kalantar-Zadeh K, Kopple JD, Humphreys MH, Block G: Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 1507-1519. (Pubitemid 38796421)
25. Girndt M, Kaul H, Sester U, et al: Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int 2002; 62: 949-955. (Pubitemid 35316724)
26. Pilz S, Dobnig H, Fischer JE, et al: Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 2008; 39: 2611-2613.
27. Kovesdy CP, Kalantar-Zadeh K: Vitamin D receptor activation and survival in chronic kidney disease. Kidney Int 2008; 73: 1355-1363. (Pubitemid 351770491)
28. Teng M, Wolf M, Ofsthun MN, et al: Activated injectable vitamin D and hemodialysis survival. J Am Soc Nephrol 2005; 16: 1115-1125. (Pubitemid 41710323)
29. Andress DL: Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int 2006; 69: 33-43. (Pubitemid 43117736)
30. Dobrez DG, Mathes A, Amdahl M, Marx SE, Melnick JZ, Sprague SM: Paracalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol patients in real world clinical settings. Nephrol Dial Transplant 2004; 19: 1174-1181. (Pubitemid 38628138)
31. Teng M, Wolf M, Lowrie E, Ofsthun M, Lazarus M, Thadhani R: Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 2003; 349: 446-456. (Pubitemid 36910023)
32. Tentori F, Albert JM, Young EW, et al: Mortality risk among hemodialysis patients receiving different vitamin D analogs. Nephrol Dial Transplant 2009; 24: 963-972.
33. Anderson JL, May HT, Horne BD, et al: Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010; 106: 963-968.
34. Kendrick J, Targher G, Smits G, Chonchol M: 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 2009; 205: 255-260.
35. Jean G, Souberbielle JC, Chazot C: Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation. Nephrol Dial Transplant 2009; 24: 3799-3805.
36. Matias PJ, Jorge C, Ferreira C, et al: Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol 2010; 5: 905-911.